DK391089D0 - Thiazolforbindelser og fremgangsmaader til fremstilling deraf - Google Patents

Thiazolforbindelser og fremgangsmaader til fremstilling deraf

Info

Publication number
DK391089D0
DK391089D0 DK391089A DK391089A DK391089D0 DK 391089 D0 DK391089 D0 DK 391089D0 DK 391089 A DK391089 A DK 391089A DK 391089 A DK391089 A DK 391089A DK 391089 D0 DK391089 D0 DK 391089D0
Authority
DK
Denmark
Prior art keywords
procedures
producing
thiazol compounds
thiazol
compounds
Prior art date
Application number
DK391089A
Other languages
English (en)
Other versions
DK391089A (da
Inventor
Hisashi Takasugi
Yousuke Katsura
Yoshikazu Inoue
Tetsuo Tomishi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888819365A external-priority patent/GB8819365D0/en
Priority claimed from GB898905818A external-priority patent/GB8905818D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of DK391089D0 publication Critical patent/DK391089D0/da
Publication of DK391089A publication Critical patent/DK391089A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK391089A 1988-08-15 1989-08-09 Thiazolforbindelser og fremgangsmaader til fremstilling deraf DK391089A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888819365A GB8819365D0 (en) 1988-08-15 1988-08-15 New furylthiazole derivatives processes for preparation thereof & pharmaceutical composition comprising same
GB898905818A GB8905818D0 (en) 1989-03-14 1989-03-14 New furylthiazole derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same

Publications (2)

Publication Number Publication Date
DK391089D0 true DK391089D0 (da) 1989-08-09
DK391089A DK391089A (da) 1990-02-16

Family

ID=26294284

Family Applications (1)

Application Number Title Priority Date Filing Date
DK391089A DK391089A (da) 1988-08-15 1989-08-09 Thiazolforbindelser og fremgangsmaader til fremstilling deraf

Country Status (12)

Country Link
EP (1) EP0355612B1 (da)
JP (1) JP2814594B2 (da)
KR (1) KR900003166A (da)
CN (1) CN1040796A (da)
AT (1) ATE109144T1 (da)
AU (1) AU3934689A (da)
DE (1) DE68917049T2 (da)
DK (1) DK391089A (da)
FI (1) FI893795A7 (da)
IL (1) IL91152A0 (da)
NO (1) NO893256L (da)
PT (1) PT91415B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
WO1993003028A1 (en) * 1991-08-02 1993-02-18 Fujisawa Pharmaceutical Co., Ltd. Furylthiazole and their use as h2-receptor antagonism and antimicrobial
GB9211163D0 (en) * 1992-05-26 1992-07-08 Fujisawa Pharmaceutical Co New oxazole derivatives
GB9326611D0 (en) * 1993-12-31 1994-03-02 Fujisawa Pharmaceutical Co New compound
DE102004008141A1 (de) 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
JPWO2016098793A1 (ja) * 2014-12-17 2017-09-28 塩野義製薬株式会社 環状グアニジル基を有するチアゾール誘導体
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003640B1 (en) * 1978-01-18 1982-01-27 Imperial Chemical Industries Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
JPS59225186A (ja) * 1983-05-18 1984-12-18 Yamanouchi Pharmaceut Co Ltd 新規なグアニジノチアゾ−ル誘導体及びその製造方法
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
JPS62273977A (ja) * 1986-05-21 1987-11-28 Yoshitomi Pharmaceut Ind Ltd フリルチアゾ−ル化合物
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents

Also Published As

Publication number Publication date
AU3934689A (en) 1990-02-15
PT91415B (pt) 1995-05-04
NO893256L (no) 1990-02-16
JP2814594B2 (ja) 1998-10-22
CN1040796A (zh) 1990-03-28
EP0355612A2 (en) 1990-02-28
IL91152A0 (en) 1990-03-19
KR900003166A (ko) 1990-03-23
EP0355612B1 (en) 1994-07-27
ATE109144T1 (de) 1994-08-15
JPH0272177A (ja) 1990-03-12
NO893256D0 (no) 1989-08-14
EP0355612A3 (en) 1990-08-22
DK391089A (da) 1990-02-16
PT91415A (pt) 1990-03-08
FI893795A7 (fi) 1990-02-16
DE68917049D1 (de) 1994-09-01
FI893795A0 (fi) 1989-08-11
DE68917049T2 (de) 1995-01-05

Similar Documents

Publication Publication Date Title
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
AU1331588A (en) Method for treatment of alcohol abuse
NZ212433A (en) Crystalline calcium pseudomonate and pharmaceutical and veterinary compositions
NO874955D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
DK122391A (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
NO862534D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser.
DK391089A (da) Thiazolforbindelser og fremgangsmaader til fremstilling deraf
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
FR2633619B1 (fr) Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
NO167456C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre
FI881097A7 (fi) Sorafeeni, menetelmä sen valmistamiseksi ja sen käyttö kasvitautien torjumiseksi
NO881303D0 (no) Underlag for pasientseng.
NZ214201A (en) Crystalline polymorph of a benzothiazine dioxide (piroxicam) salt, and pharmaceutical compositions
NO880292L (no) Fremgangsmaate for behandling av humle.
DK514285D0 (da) 5-cyanopyridin-2-diazohydroxid, basiske salte og fremgangsmaader til deres fremstilling og anvendelse
HUT53288A (en) Process for production of medical compositions for animals against endoparasite
RU92016264A (ru) Новые соединения, способ их получения, фармацевтический состав, его получение, способ профилактики или лечения, применение соединений
DK226688D0 (da) Middel til behandling og forebyggelse af asthma

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment